All News

A universal aspirin initiative at a Bronx hospital increased prescribing rates from 30% to 99% and is now being evaluated for its impact on preeclampsia.

New research highlights that women giving birth at age 30 years or older face significantly increased odds of pelvic organ prolapse.

A low-fat, soy-rich vegan diet significantly decreases severe hot flashes and supports healthy weight loss, according to new research.

A phase 3 trial shows elinzanetant effectively reduces hot flashes and improves quality of life in patients undergoing hormone therapy for hormone-receptor-positive breast cancer.

Considerations for reducing blood loss, morbidity, and surgical complexity in patients with large fibroids.

A new study reveals that emotional symptoms such as anger and feeling out of control intensify before menstruation and become more severe during the menopause transition.

Integrating oral health checks into standard clinical assessments can improve overall patient outcomes and reduce the risk of systemic diseases linked to gum and dental issues.

New research reveals a strong genetic connection in postpartum psychosis, emphasizing the need for early screening in high-risk women.

Take a quick look at everything you may have missed last month, including the latest FDA updates, top stories, and exclusive interviews.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

A new study reveals that combined oral contraceptive use significantly increases the risk of cryptogenic stroke in women aged 18 to 49 years, highlighting the need for careful risk assessment.

Women with dense breast tissue face higher cancer risks and diagnostic challenges, but new research reveals contrast imaging may significantly improve early detection.

A new study reveals worsening mental and physical health among female parents, highlighting growing disparities across race, income, and family structure.

A new University of British Columbia study reveals that mild breast symptoms before menstruation are more common in cycles with normal ovulation than in disturbed ones.

GSK and Spero Therapeutics announced that the phase 3 PIVOT-PO trial for tebipenem HBr, a potential first oral carbapenem for cUTIs in the United States, was stopped early because of positive efficacy results.

A new study shows that a self-collected cervical cancer screening device is highly accurate, easy to use, and preferred over clinician collection.

RFK Jr. stated he "couldn't be more pleased" to announce that COVID-19 vaccination among healthy children and pregnant women has been removed from CDC's immunization schedule.

Women living in neighborhoods with very high social vulnerability are more likely to experience natural menopause at a younger age, according to new research.

A new study finds that a daily 150 mg dose of aspirin significantly improves thromboxane B2 inhibition compared to 75 mg in pregnant women at risk for preeclampsia.

A new study highlights how dismissive medical experiences, including gaslighting, contribute to emotional distress and care avoidance among patients with vulvovaginal disorders.

A thoughtful approach to behavioral change.

In this Q&A, Karyn S. Eilber, MD, shares some of the biggest takeaways from the new AUA/SUFU/AUGS 2025 Guidelines on Genitourinary Syndrome of Menopause.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

A new study finds that Texas' restrictive abortion law significantly increased rates of mental distress among reproductive-aged women, especially those aged 18 to 29 years.

Angie Lee, MD, FACOG, discusses how clinicians can bridge the gap in menopause care to ensure better outcomes for their patients.

A study found that biologic treatment rates decline during pregnancy and only partially rebound postpartum, with trends varying by autoimmune condition.

Find out what you may have missed at the 2025 ACOG ACSM.

Watch some highlights from our discussions with experts presenting at the 2025 ACOG meeting.